- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1993
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Biosimilar Uptake: The Importance of Healthcare Provider Education ; volume:35 ; number:4 ; day:22 ; month:8 ; year:2021 ; pages:215-224 ; date:7.2021
Pharmaceutical medicine ; 35, Heft 4 (22.8.2021), 215-224, 7.2021
- Urheber
-
Oskouei, Sonia Tadjalli
Kusmierczyk, Andrew R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40290-021-00396-7
- URN
-
urn:nbn:de:101:1-2021111818075395864693
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Oskouei, Sonia Tadjalli
- Kusmierczyk, Andrew R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The Importance of Countering Biosimilar Disparagement and Misinformation
Biosimilar uptake by British local formularies: a cross sectional study
Choice of healthcare provider following reform in Vietnam
Understanding healthcare provider absenteeism in Kenya: a qualitative analysis
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story
Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
AVT02: An Adalimumab Biosimilar
SB8: A Bevacizumab Biosimilar
AVT04: An Ustekinumab Biosimilar
Healthcare Provider Experience in Diagnosing and Treating Cutaneous T-Cell Lymphoma
The Importance of Countering Biosimilar Disparagement and Misinformation
Biosimilar uptake by British local formularies: a cross sectional study
Choice of healthcare provider following reform in Vietnam
Understanding healthcare provider absenteeism in Kenya: a qualitative analysis
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story
Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
AVT02: An Adalimumab Biosimilar
SB8: A Bevacizumab Biosimilar
AVT04: An Ustekinumab Biosimilar
Healthcare Provider Experience in Diagnosing and Treating Cutaneous T-Cell Lymphoma
The Importance of Countering Biosimilar Disparagement and Misinformation
Biosimilar uptake by British local formularies: a cross sectional study
Choice of healthcare provider following reform in Vietnam
Understanding healthcare provider absenteeism in Kenya: a qualitative analysis
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story
Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
AVT02: An Adalimumab Biosimilar
SB8: A Bevacizumab Biosimilar
AVT04: An Ustekinumab Biosimilar